Company: NGVT
Filing Date: 2025-02-19
Form Type: 10-K
Source: 0001653477-25-000015
Chunk: 1121

Company: Ingevity Corp
Filing Date: 2025-02-19
Form: 10-K
Item: Item 8
Chunk 1121
---
 shows a roll forward of restructuring reserves that will result in cash spending, the majority of which relate to the Performance Chemicals' repositioning.Balance atChange inCashBalance atIn millions12/31/2023 (1)Reserve (2)PaymentsOther (3)12/31/2024 (1)Severance and other employee-related costs$7.3 10.1 (13.0)(0.2)$4.2 Other charges (income)0.9 40.1 (39.9)(0.2)0.9 Restructuring8.2 50.2 (52.9)(0.4)5.1 Other (income) charges, net— 6.4 (6.4)— — Restructuring and Other (income) charges, net reserves$8.2 56.6 (59.3)(0.4)$5.1 Balance atChange inCashBalance atIn millions12/31/2022 (1)Reserve (2)PaymentsOther (3)12/31/2023 (1)Severance and other employee-related costs$— 8.6 (1.5)0.2 $7.3 Other charges (income)0.5 11.4 (11.0)— 0.9 Restructuring0.5 20.0 (12.5)0.2 8.2 Other (income) charges, net— 31.5 (31.5)— — Restructuring and Other (income) charges, net reserves$0.5 51.5 (44.0)0.2 $8.2 _______________(1) Included in "Accrued expenses" on the consolidated balance sheets. (2) Includes severance and other employee-related costs, exited leases, CTO supply contract terminations and other miscellaneous exit costs. Any asset write-downs including accelerated depreciation and impairment charges are not included in the above table.(3) Primarily foreign currency translation adjustments.

92

IndexIngevity CorporationNotes to the Consolidated Financial StatementsDecember 31, 2024

Note 16: Acquisitions

Ozark MaterialsOn October 3, 2022, pursuant to that certain Equity Purchase Agreement (the “Purchase Agreement”), by and among Ingevity, Ozark Materials,